ADPriboDB 2.0: an updated database of ADP-ribosylated proteins.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
08 01 2021
Historique:
accepted: 31 10 2020
revised: 05 10 2020
received: 15 09 2020
pubmed: 3 11 2020
medline: 26 1 2021
entrez: 2 11 2020
Statut: ppublish

Résumé

ADP-ribosylation is a protein modification responsible for biological processes such as DNA repair, RNA regulation, cell cycle and biomolecular condensate formation. Dysregulation of ADP-ribosylation is implicated in cancer, neurodegeneration and viral infection. We developed ADPriboDB (adpribodb.leunglab.org) to facilitate studies in uncovering insights into the mechanisms and biological significance of ADP-ribosylation. ADPriboDB 2.0 serves as a one-stop repository comprising 48 346 entries and 9097 ADP-ribosylated proteins, of which 6708 were newly identified since the original database release. In this updated version, we provide information regarding the sites of ADP-ribosylation in 32 946 entries. The wealth of information allows us to interrogate existing databases or newly available data. For example, we found that ADP-ribosylated substrates are significantly associated with the recently identified human protein interaction networks associated with SARS-CoV-2, which encodes a conserved protein domain called macrodomain that binds and removes ADP-ribosylation. In addition, we create a new interactive tool to visualize the local context of ADP-ribosylation, such as structural and functional features as well as other post-translational modifications (e.g. phosphorylation, methylation and ubiquitination). This information provides opportunities to explore the biology of ADP-ribosylation and generate new hypotheses for experimental testing.

Identifiants

pubmed: 33137182
pii: 5952204
doi: 10.1093/nar/gkaa941
pmc: PMC7778992
doi:

Substances chimiques

Proteins 0
Viral Proteins 0
Adenosine Diphosphate Ribose 20762-30-5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D261-D265

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM104135
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009110
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Cell Rep. 2018 Aug 28;24(9):2493-2505.e4
pubmed: 30157440
ACS Omega. 2020 Jan 22;5(4):1743-1751
pubmed: 32039309
Mol Cell. 2015 Jun 18;58(6):911-24
pubmed: 26091340
Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
J Virol. 2020 Nov 6;:
pubmed: 33158944
Genes Dev. 2020 Mar 1;34(5-6):341-359
pubmed: 32029454
Mol Cell. 2019 Feb 21;73(4):845-856.e5
pubmed: 30712989
Cell Rep. 2018 Sep 25;24(13):3488-3502.e5
pubmed: 30257210
Annu Rev Biochem. 2015;84:227-63
pubmed: 25747399
Viruses. 2020 Mar 31;12(4):
pubmed: 32244383
FEBS J. 2005 Sep;272(18):4565-75
pubmed: 16156779
Nucleic Acids Res. 2017 Jan 4;45(D1):D204-D209
pubmed: 27507885
Biochem Biophys Res Commun. 1963 Apr 2;11:39-43
pubmed: 14019961
Nucleic Acids Res. 2016 Jan 4;44(D1):D435-46
pubmed: 26578568
Biochemistry. 2020 Jul 21;59(28):2608-2615
pubmed: 32578982
PLoS Pathog. 2018 Mar 22;14(3):e1006864
pubmed: 29566066
Nat Rev Microbiol. 2014 Sep;12(9):599-611
pubmed: 25023120
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Genes Dev. 2020 Mar 1;34(5-6):302-320
pubmed: 32029452
Genes Dev. 2020 Mar 1;34(5-6):263-284
pubmed: 32029451
Sci Rep. 2018 Oct 19;8(1):15512
pubmed: 30341374
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621
pubmed: 28676700
Nat Rev Mol Cell Biol. 2012 Mar 07;13(4):225-238
pubmed: 22395773
Mol Omics. 2018 Jun 12;14(3):197-209
pubmed: 29876573
Biochemistry. 2018 Jan 30;57(4):429-440
pubmed: 29327913
Nature. 2020 Mar;579(7800):598-602
pubmed: 32028527
Mutat Res. 2019 Apr - Jun;780:82-91
pubmed: 31395352
Science. 2016 Jul 1;353(6294):45-50
pubmed: 27256882
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
FEBS J. 2017 Sep;284(18):2932-2946
pubmed: 28383827
Nucleic Acids Res. 2019 Jan 8;47(D1):D298-D308
pubmed: 30418626
ACS Chem Biol. 2013 Jul 19;8(7):1567-75
pubmed: 23631432
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Trends Biochem Sci. 2010 Apr;35(4):208-19
pubmed: 20106667
Genes Dev. 2017 Jan 15;31(2):101-126
pubmed: 28202539

Auteurs

Vinay Ayyappan (V)

Department of Biomedical Engineering, The G.W.C. Whiting School of Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.

Ricky Wat (R)

Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Calvin Barber (C)

Department of Biophysics, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.

Christina A Vivelo (CA)

Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Kathryn Gauch (K)

Department of Biology, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.

Pat Visanpattanasin (P)

Department of Biology, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.

Garth Cook (G)

Department of Biology, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.

Christos Sazeides (C)

Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Anthony K L Leung (AKL)

Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Department of Molecular Biology and Genetics, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH